Intent: Ensure Ireland remains vocal against tariffs/ retaliatory tariffs on medicines and pharmaceutical ingredients; Ensure Ireland understands potential impacts of MFN policy and recognises the need for Ireland (and Europe) to appropriately value innovation closing the gap between Europe and the US; in Ireland specifically the Framework Supply Agreement and RSV immunisation
Details: Geopolitical polices in relation to tariffs and Most Favoured Nation (MFN) pricing
Intent: To discuss with the Tánaiste and Minister for Finance Simon Harris (with IDA participation) the need to strengthen vaccine confidence, Ireland’s pro innovation policy environment, improve access to medicines, and elevate cardiovascular public health priorities across the EU, together with reaffirming MSD’s 50-year partnership with Ireland.
Intent: To support the work of the Irish Government on the establishment of a EU Pharma Task Force of Member States to support the pharmaceutical industry in the EU.
Intent: Highlight the impact of US tariffs and trade uncertainty on the export focussed Irish drinks manufacturing sector and for Government action on supports for the sector
Details: Policy priorities for the Irish drinks sector
Intent: To highlight our concerns about the inclusion of pharmaceuticals in tariffs, the timing for entry into force, and the need for a zero-tariff pathway that includes innovative medicines. ::To highlight the potential impact of Most Favoured Nation pricing for pharmaceuticals in the US and the need for further investment in innovative medicines in Europe that recognises the value of biopharmaceutical innovation
Details: Raise concern about the impact of potential tariffs and related geo-political issues related to the pharmaceutical industry and pricing of medicines globally
Intent: Highlighting the exposure of the drinks sector to US tariffs and the need for govt actions to support the sector including a pause in proposals re labelling.
Details: Proposals to help promote the Irish drinks sector
Intent: To raise awareness of the economic value of personalized ads and the potential impact of the European Commission's investigation of Meta under the Digital Markets Act.
Details: To discuss the European Commission's investigation of Meta under the Digital Markets Act.